Literature DB >> 14524260

[Contemporary views on the pathological mechanism of asthma].

Piotr Kuna1.   

Abstract

Asthma is a chronic inflammatory disease of the airways. Genetic and environmental factors contribute to the development of asthma. Both inflammation and remodelling are essential mechanisms in the development of subepithelial fibrosis and smooth muscle hypertrophy leading to progressing decrease of FEV1. Inflammatory changes in asthma are characterised by cellular infiltration of airway epithelium, bronchial wall and smooth muscle layer. The most important cells participating in asthma include T lymphocytes, mast cells, airway epithelial cells, eosinophils, antigen-presenting cells, neutrophils, fibroblasts, myofibroblasts and macrophages. They produce many cytokines responsible for the development of allergen-specific clones of Th2 lymphocytes, for production of IgE by B-cells, for increased expression of adhesion molecules, for migration of cells, their activation and release of inflammatory mediators. The mediators coming mainly from mast cells and eosinophils that include leukotrienes, prostaglandins, histamine, alkaline proteins and enzymes are responsible for airway obturation that results from bronchospasm, bronchial mucosal oedema and excessive amount of abnormal mucous secretion. An important role in the obturation is played by smooth muscle hypertrophy and deposition of proteins under the basal membranes of respiratory epithelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14524260

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

1.  Sanao decoction for asthma: Protocol of a systematic review.

Authors:  Guoming Chen; Yijun Chen; Ziyin Chen; Shuai Gao; Peng Zhang; Honghui Zhang; Yanfen Huang; Yingtong Lin; Li Wei
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

2.  Expression of vitamin D receptor in bronchial asthma and its bioinformatics prediction.

Authors:  Lishen Shan; Xinyuan Kang; Fen Liu; Xuxu Cai; Xiaohua Han; Yunxiao Shang
Journal:  Mol Med Rep       Date:  2018-06-13       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.